FYBLOCA Trademark

Trademark Overview

On Friday, October 9, 2015, a trademark application was filed for FYBLOCA with the United States Patent and Trademark Office. The USPTO has given the FYBLOCA trademark a serial number of 86783360. The federal status of this trademark filing is REGISTERED as of Tuesday, May 21, 2019. This trademark is owned by Gilead Sciences Ireland UC. The FYBLOCA trademark is filed in the Pharmaceutical Products category with the following description:

antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, oncological, and hematological conditions, diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations; syringes sold filled with pharmaceutical preparations for the treatment of inflammation, fibrosis, hepatic, cardiovascular, respiratory, oncological, and hematological conditions, diseases and disorders
fybloca

General Information

Serial Number86783360
Word MarkFYBLOCA
Filing DateFriday, October 9, 2015
Status700 - REGISTERED
Status DateTuesday, May 21, 2019
Registration Number5754182
Registration DateTuesday, May 21, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2016

Trademark Statements

Goods and Servicesantiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, oncological, and hematological conditions, diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations; syringes sold filled with pharmaceutical preparations for the treatment of inflammation, fibrosis, hepatic, cardiovascular, respiratory, oncological, and hematological conditions, diseases and disorders
Translation of Words in MarkThe wording "FYBLOCA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 15, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill Co. Cork,
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Monday, October 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 21, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 15, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, April 11, 2019NOTICE OF ALLOWANCE CANCELLED
Thursday, April 11, 2019TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, October 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 22, 2018EXTENSION 5 GRANTED
Monday, October 15, 2018EXTENSION 5 FILED
Monday, October 22, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 15, 2018TEAS EXTENSION RECEIVED
Tuesday, April 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 20, 2018EXTENSION 4 GRANTED
Friday, April 20, 2018EXTENSION 4 FILED
Friday, April 20, 2018TEAS EXTENSION RECEIVED
Wednesday, October 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 9, 2017EXTENSION 3 GRANTED
Monday, October 9, 2017EXTENSION 3 FILED
Monday, October 9, 2017TEAS EXTENSION RECEIVED
Thursday, April 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 18, 2017EXTENSION 2 GRANTED
Tuesday, April 18, 2017EXTENSION 2 FILED
Tuesday, April 18, 2017TEAS EXTENSION RECEIVED
Friday, October 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 19, 2016EXTENSION 1 GRANTED
Wednesday, October 19, 2016EXTENSION 1 FILED
Wednesday, October 19, 2016TEAS EXTENSION RECEIVED
Tuesday, June 14, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 14, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 7, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, March 7, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 4, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 4, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 26, 2016ASSIGNED TO LIE
Thursday, February 18, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 21, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 21, 2015NON-FINAL ACTION E-MAILED
Monday, December 21, 2015NON-FINAL ACTION WRITTEN
Monday, December 21, 2015ASSIGNED TO EXAMINER
Thursday, October 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 13, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

fybloca pharmaceutical preparations treatment diseases oncological conditions disorders respiratory hematological cardiovascular